Gastroenterology
Volume 137, Issue 5 , Pages 1649-1660 , November 2009

Serotonin Has a Key Role in Pathogenesis of Experimental Colitis

  • Jean–Eric Ghia

      Affiliations

    • Farncombe Family Digestive Health Research Institute, Departments of Pathology & Molecular Medicine & Medicine, McMaster University, Ontario, Canada
    • ,
  • Nan Li

      Affiliations

    • Farncombe Family Digestive Health Research Institute, Departments of Pathology & Molecular Medicine & Medicine, McMaster University, Ontario, Canada
    • ,
  • Huaqing Wang

      Affiliations

    • Farncombe Family Digestive Health Research Institute, Departments of Pathology & Molecular Medicine & Medicine, McMaster University, Ontario, Canada
    • ,
  • Matthew Collins

      Affiliations

    • Farncombe Family Digestive Health Research Institute, Departments of Pathology & Molecular Medicine & Medicine, McMaster University, Ontario, Canada
    • ,
  • Yikang Deng

      Affiliations

    • Farncombe Family Digestive Health Research Institute, Departments of Pathology & Molecular Medicine & Medicine, McMaster University, Ontario, Canada
    • ,
  • Rami T. El–Sharkawy

      Affiliations

    • Farncombe Family Digestive Health Research Institute, Departments of Pathology & Molecular Medicine & Medicine, McMaster University, Ontario, Canada
    • ,
  • Francine Côté

      Affiliations

    • Laboratoire de génétique moléculaire de la neurotransmission et des processus neuro-dégénératifs, CNRS Université Paris-VI, Paris, France
    • ,
  • Jacques Mallet

      Affiliations

    • Laboratoire de génétique moléculaire de la neurotransmission et des processus neuro-dégénératifs, CNRS Université Paris-VI, Paris, France
    • ,
  • Waliul I. Khan

      Affiliations

    • Farncombe Family Digestive Health Research Institute, Departments of Pathology & Molecular Medicine & Medicine, McMaster University, Ontario, Canada
    • Corresponding Author InformationReprint requests Address requests for reprints to: Waliul I. Khan, MD, PhD, Department of Pathology & Molecular Medicine, Room 2N34, McMaster University Medical Center, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada

Received 4 March 2009 ,Accepted 6 August 2009.

References 

  1. Podolsky DK. Inflammatory bowel disease (2). N Engl J Med. 1991;325:1008–1016
  2. Qiu BS, Vallance BA, Blennerhassett PA, et al. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med. 1999;5:1178–1182
  3. Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3(Suppl 2):S25–S34
  4. Ham TS. Regional distribution and relative frequency of gastrointestinal endocrine cells in large intestines of C57BL/6 mice. J Vet Sci. 2002;3:233–238
  5. Ku SK, Lee HS, Lee JH. An immunohistochemical study of gastrointestinal endocrine cells in the BALB/c mouse. Anat Histol Embryol. 2004;33:42–48
  6. Nagata K, Fujimiya M, Sugiura H, et al. Intracellular localization of serotonin in mast cells of the colon in normal and colitis rats. Histochem J. 2001;33:559–568
  7. Buchan AM. Nutrient tasting and signaling mechanisms in the gut III (Endocrine cell recognition of luminal nutrients). Am J Physiol. 1999;277:G1103–G1107
  8. Fitzpatrick PF. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem. 1999;68:355–381
  9. Walther DJ, Peter JU, Bashammakh S, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76
  10. Ahonen A, Kyosola K, Penttila O. Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon. Ann Clin Res. 1976;8:1–7
  11. Bishop AE, Pietroletti R, Taat CW, et al. Increased populations of endocrine cells in Crohn's ileitis. Virchows Arch A Pathol Anat Histopathol. 1987;410:391–396
  12. Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126:1657–1664
  13. El-Salhy M, Danielsson A, Stenling R, et al. Colonic endocrine cells in inflammatory bowel disease. J Intern Med. 1997;242:413–419
  14. Farmer SG, Laniyonu AA. Effects of p-chlorophenylalanine on the sensitivity of rat intestine to agonists and on intestinal 5-hydroxytryptamine levels during Nippostrongylus brasiliensis infection. Br J Pharmacol. 1984;82:883–889
  15. Kordasti S, Sjovall H, Lundgren O, et al. Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea. Gut. 2004;53:952–957
  16. Moore BA, Sharkey KA, Mantle M. Role of 5-HT in cholera toxin-induced mucin secretion in the rat small intestine. Am J Physiol. 1996;270:G1001–G1009
  17. Wang H, Steeds J, Motomura Y, et al. CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut. 2007;56:949–957
  18. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut. 1998;42:42–46
  19. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–811
  20. Nocito A, Dahm F, Jochum W, et al. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. Cancer Res. 2008;68:5152–5158
  21. Khan WI, Motomura Y, Wang H, et al. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol. 2006;291:G803–G811
  22. Linden DR, Chen JX, Gershon MD, et al. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;285:G207–G216
  23. Oshima S, Fujimura M, Fukimiya M. Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate. Histochem Cell Biol. 1999;112:257–263
  24. Bischoff SC, Mailer R, Pabst O, et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol. 2009;296:G685–G695
  25. Motomura Y, Ghia JE, Wang H, et al. Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments. Gut. 2008;57:475–481
  26. Cote F, Thevenot E, Fligny C, et al. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A. 2003;100:13525–13530
  27. Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104–107
  28. Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238–249
  29. Khan WI, Blennerhasset PA, Varghese AK, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun. 2002;70:5931–5937
  30. Smith JW, Castro GA. Relation of peroxidase activity in gut mucosa to inflammation. Am J Physiol. 1978;234:R72–R79
  31. Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest. 2008;118:2209–2218
  32. Kruisbeek M, Vogel S. Innate immunity: isolation of murine macrophage. Current Protocol Immunol. 2002;14.1.1–14.2.8
  33. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694–702
  34. Cloez-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol. 2007;81:599–606
  35. Freire-Garabal M, Nunez MJ, Balboa J, et al. Serotonin upregulates the activity of phagocytosis through 5-HT1A receptors. Br J Pharmacol. 2003;139:457–463
  36. Cole JA, Cook SF, Sands BE, et al. Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol. 2004;99:486–491
  37. DiBaise JK. Tegaserod-associated ischemic colitis. Pharmacotherapy. 2005;25:620–625
  38. Knudsen JF, Friedman B, Chen M, et al. Ischemic colitis and sumatriptan use. Arch Intern Med. 1998;158:1946–1948
  39. Ladabaum U. Safety, efficacy and costs of pharmacotherapy for functional gastrointestinal disorders: the case of alosetron and its implications. Aliment Pharmacol Ther. 2003;17:1021–1030
  40. Harbuz MS, Perveen-Gill Z, Lalies MD, et al. The role of endogenous serotonin in adjuvant-induced arthritis in the rat. Br J Rheumatol. 1996;35:112–116
  41. Hrycaj P. Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions—preliminary clinical experience. Scand J Rheumatol Suppl. 2004;55–58

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by grants from Crohn's and Colitis Foundation of Canada and the Canadian Institutes of Health Research (to W.I.K.).

PII: S0016-5085(09)01456-5

doi: 10.1053/j.gastro.2009.08.041

Gastroenterology
Volume 137, Issue 5 , Pages 1649-1660 , November 2009

Article Tools

* Image Usage & Resolution